Skip to main content
PRAX
NASDAQ Life Sciences

Praxis Posts $94.2M Q3 Loss, $1.3B Cash Ahead of Two FDA Decisions

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$270
Mkt Cap
$7.751B
52W Low
$159.735
52W High
$392.7
52W Position info
69% above low
Off High info
31% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PRAX sits 69% above its 52-week low of $159.735.

Summary

Praxis reported a Q3 2026 net loss of $94.2M, wider than the $73.9M loss a year ago, as G&A expense jumped to $42.7M from $12.6M while R&D slipped to $64.2M from $65.8M. The loss per share was $3.23. Cash and investments stood at $1.3B on September 30, 2026, up from $926.1M at December 31, 2025, with the company guiding runway into 2028. The balance sheet removes near-term financing risk, but the widening loss and G&A step-up are the numbers to weigh against the clinical story. Two FDA decisions anchor the thesis: relutrigine has a PDUFA date of December 27, 2026, and ulixacaltamide January 29, 2027. EMERALD topline results are expected in the fourth quarter of 2026.

At the time of this announcement, PRAX was trading at $270.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.8B. The 52-week trading range was $159.74 to $392.70. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PRAX - Latest Insights

PRAX
Nov 09, 2026, 7:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $270.00
Real-time Price: $270.00 info
Change: $0 (0%) info
Market Cap: $7.751B info
PRAX
Aug 06, 2026, 8:32 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $337.00
Real-time Price: $270.00 info
Change: -$67.00 (-20%) info
Market Cap: $7.751B info
PRAX
Aug 06, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $337.10
Real-time Price: $270.00 info
Change: -$67.10 (-20%) info
Market Cap: $7.751B info
PRAX
Jul 07, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $330.00
Real-time Price: $270.00 info
Change: -$60.00 (-18%) info
Market Cap: $7.751B info
PRAX
Jun 29, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $334.00
Real-time Price: $270.00 info
Change: -$64.00 (-19%) info
Market Cap: $7.751B info